Clinical Trials
2 trialsNCT00302757 2014-05-29
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
University Hospital Tuebingen
Phase 1/2 Completed
NCT00177554 2008-05-29
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
University of Pittsburgh
Phase 2 Completed